ro 24-4736 has been researched along with web 2086 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crowley, H; Flynn, T; Maresca, C; Mason, C; O'Donnell, M; Walser, A; Yaremko, B | 1 |
| Burghardt, C; Crowley, HJ; Janero, DR; O'Donnell, M; Selig, WM; Welton, AF; Yaremko, B | 1 |
2 other study(ies) available for ro 24-4736 and web 2086
| Article | Year |
|---|---|
Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.
Topics: Animals; Azepines; Benzodiazepines; Blood Platelets; Bronchoconstriction; Chemical Phenomena; Chemistry; Dogs; Guinea Pigs; Male; Molecular Conformation; Molecular Structure; Platelet Activating Factor; Structure-Activity Relationship; Thiophenes; Triazoles | 1991 |
Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
Topics: Animals; Azepines; Binding Sites; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchodilator Agents; Dogs; Guinea Pigs; Humans; Male; Phenanthridines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Triazines; Triazoles | 1991 |